secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scholar Rock Holding Corp (SRRK)
CIK:        0001727196
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001104659-25-098894
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Scholar Rock notified that FDA classifies Catalent Indiana facility as 'official action indicated'
--------------------------------------------------------------------------------

- Novo Nordisk informed Scholar Rock on Oct 10 that FDA classified Catalent Indiana (owned by Novo Nordisk) as 'official action indicated' (OAI).
- OAI classification follows a Form FDA 483 issued July 14, 2025, citing significant objectionable conditions at the facility.
- Filing does not specify the impact on Scholar Rock's manufacturing, supply chain, or regulatory timelines.
- Scholar Rock provided no assessment of potential delays or financial effect in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1727196/000110465925098894/0001104659-25-098894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1727196/000110465925098894/tm2528675d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer